Alto Neuroscience, Inc. Common Stock (ANRO)
EBITDA Growth
-30.48%
TTM · Period ending:
ANRO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-30.48%period ending
Latest reported-30.48%period ending
ANRO TTM EBITDA YoY % (-77.33% → -30.48%)
Year-over-year change
High-resolution chart · PNG
ANRO ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -30.4762% | |
| -16.7858% | |
| -0.9302% | |
| -6.7074% | |
| -29.7181% | |
| -49.8943% | |
| -72.211% | |
| -77.3304% |